US 9233973
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same
granted A61KA61K31/165A61K31/167
Quick answer
US patent 9233973 (Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/165, A61K31/167, A61K31/192, A61K31/195